Last reviewed · How we verify
Alzheimer's disease
Approved treatments
- Amiridine
Amiridine works by inhibiting the enzyme Acetylcholinesterase, which breaks down the neurotransmitter acetylcholine. - Neuraceq · Life Molecular
- Neuraceq · Life Molecular
- Razadyne · Johnson & Johnson
Razadyne works by blocking the enzyme that breaks down acetylcholine, allowing more of this neurotransmitter to be available in the brain. - Vizamyl · Ge Healthcare
Vizamyl works by binding to amyloid plaques in the brain, allowing for visualization through positron emission tomography (PET) imaging. - Vizamyl · Ge Healthcare
Vizamyl works by binding to amyloid plaques in the brain, allowing for visualization through positron emission tomography (PET) imaging. - Donepezil (Aricept) · University of Virginia
- Exelon · US Department of Veterans Affairs
- Exelon · Novartis
- Aduhelm · Biogen
- Aricept · Eisai Korea Inc.
- ADUHELM · BIOGEN INC
- Levocarnitine Acetyl
Acetylcarnitine works by supporting the transport of fatty acids into mitochondria, where they can be used for energy production. - Beta-Dihydroergocryptine
- LEQEMBI · EISAI INC
- Amyvid · Avid Radiopharms Inc
Amyvid binds to beta-amyloid plaques in the brain, allowing for visualization of these plaques through PET imaging. - Amyvid · Avid Radiopharms Inc
Amyvid binds to beta-amyloid plaques in the brain, allowing for visualization of these plaques through PET imaging. - Aricept · Eisai
Aricept works by blocking the enzyme that breaks down a key neurotransmitter in the brain, acetylcholine. - Leqembi · Eisai
Leqembi works by binding to and removing amyloid beta A4 protein from the brain, which is thought to contribute to the progression of Alzheimer's disease.
Pipeline
- VALACYCLOVIR — Phase 2
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Alzheimer's disease patent landscape — cliff calendar, originator estates, attackable patents
- Alzheimer's disease treatment landscape brief
- Alzheimer's disease treatment updates RSS
Frequently asked questions about Alzheimer's disease
What drugs treat Alzheimer's disease?
Tracked treatments include Amiridine, Neuraceq, Razadyne, Vizamyl, Donepezil (Aricept), Exelon, Aduhelm, Aricept.
What is the treatment for Alzheimer's disease?
Standard treatment for Alzheimer's disease includes Amiridine, Neuraceq, Razadyne, Vizamyl, Donepezil (Aricept). See the treatment landscape page for first-line, second-line and salvage options.
What new drugs are in development for Alzheimer's disease?
1 pipeline drugs tracked. Top candidates: VALACYCLOVIR.
Related
- Treatment landscape: Alzheimer's disease patent cliff · Alzheimer's disease CI report
- Treatment: Amiridine
- Treatment: Neuraceq · Life Molecular
- Treatment: Neuraceq · Life Molecular
- Treatment: Razadyne · Johnson & Johnson
- Treatment: Vizamyl · Ge Healthcare
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing